News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Either way, soda is not the greatest thing to drink – Naoto T Ueno
Naoto Ueno/LinkedIn
Jul 14, 2023, 18:53

Either way, soda is not the greatest thing to drink – Naoto T Ueno

Aspartame Is a Possible Cause of Cancer in Humans, a W.H.O. Agency Says. But FDA does not agree. You must drink about a dozen cans of diet soda daily. Either way, soda is not the greatest thing to drink.

Source: Naoto T Ueno/Twitter

Aspartame cancer FDA Naoto T Ueno OncoDaily Oncology soda
Special Coverage
Blog
Apr 15, 2025, 12:02
Early registration is closing for the ESMO Gynaecological Cancers 2025
Blog
Apr 15, 2025, 11:54
Esosa Omoregie: Day 2 at ASBMB 2025 - Insights, networking, and career growth
Blog
Apr 15, 2025, 11:52
Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC
Career
Apr 15, 2025, 11:46
Merel Hennink has been appointed to the Board of Lung Cancer Europe
Oncolibrary
Apr 15, 2025, 11:34
New Paper Alert: Insights from the PALMARES-2 Study: Improved Outcomes with Abemaciclib and Ribociclib in HR+/HER2- ABC
Blog
Apr 15, 2025, 11:34
Insightful updates and lively discussions at the EUonQoL General Assembly - European Cancer Organisation
Blog
Apr 15, 2025, 11:30
Moshe Ornstein as the moderator for KidneyCAN's upcoming Town Hall
Blog
Apr 15, 2025, 11:20
Support cancer research that creates better treatments for pediatric cancer patients - NFCR
Insight
Apr 15, 2025, 11:00
Roberto Vasquez Sheds Light on LMICs' Struggles with Cancer Drug Access
Blog
Apr 15, 2025, 10:52
The first lectures of the Masterclass on Gynecopathology by Matias-Guiu - European Society of Pathology
Insight
Apr 15, 2025, 10:23
Anna Avagyan on Armenia's ACT4Children Program and Genetic Risk Clinics
Blog
Apr 15, 2025, 10:22
Yizhou Zhang Discusses Innovation in Pediatric Cancer Drug Access in China